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Venous thrombosis affects approximately one in a thousand individuals per year. A 
gain-of-function in the factor V gene, factor V Leiden (FVL) is the most common 
known inherited risk factor for venous thrombosis. Penetrance is incomplete, with 
only ~10% of FVL individuals experiencing clinically significant thrombosis in their 
lifetimes. We are performing a whole genome mutagenesis screen to identify 
candidates for the modifier genes responsible for the incomplete penetrance and 
variable expressivity of FVL in humans. Previously, we demonstrated synthetic 
lethality between FVL and genetic deficiency of a key coagulation pathway 
regulatory factor, tissue factor pathway inhibitor (TFPI). Complete TFPI deficiency in 
mice is embryonic lethal, whereas heterozygosity is compatible with normal 
survival. However, homozygosity for FVL (FvQ/Q) in the context of heterozygosity 
for TFPI (Tfpi+/-) is uniformly lethal due to disseminated perinatal thrombosis. This 
synthetic lethal interaction was utilized as a phenotyping tool for a sensitized ENU 
mutagenesis screen. We aim to uncover novel dominant mutations that improve 
hemostatic balance leading to survival of FvQ/Q Tfpi+/- mice. Male FvQ/Q mice 
were mutagenized with a single ENU dose of 150 mg/kg, bred to FvQ/+ Tfpi+/- 
double heterozygous females. Surviving G1 offspring were analyzed to identify 
rescued mice with the FvQ/Q Tfpi+/- genotype. Analysis of 284 G1 offspring to date 
has identified six mice that survived to weaning, with two rescued animals surviving 
to >5 months of age. Based on these results, an expanded screen is underway, 
along with efforts to map the currently identified rescuing mutation.
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